ApcinteX
ApcinteX develops and markets anticoagulant APC pathway to treat haemophilia.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed ApcinteX Information
Geographic Data
Address:
City: London
State: England
Zip:
Country: United Kingdom
Financial Info
Stage:
series a
Raised Last:
$18M
Raised Total:$18M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
ApcinteX develops and markets anticoagulant APC pathway to treat haemophilia. Apcintex has developed a new treatment that seeks to turn down the activity of a key natural anticoagulant pathway to produce normal blood clotting in patients with haemophilia. This means that the drug could potentially treat patients with all types of haemophilia, including those who develop antibodies to replacement factors. Furthermore, the drug does not cause anti-clotting antibodies to form and could be administered fortnightly by simple injection under the skin.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2017 | Series A | 2 | $17.5M |
Medicxi Touchstone Innovations Medicxi Touchstone Innovations |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
